The neuropathology associated with repeat expansions in the C9ORF72 gene

Acta Neuropathologica

Volumn 127, Issue 3, 2014, Pages 347-357

  Mackenzie, Ian R A ^a   Frick, Petra ^b   Neumann, Manuela ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR RNA; PROTEIN P62; TAR DNA BINDING PROTEIN; UBIQUITIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOPSY; CELL NUCLEUS INCLUSION BODY; CEREBELLUM; CHROMOSOME 9 OPEN READING FRAME 72 GENE; FRONTAL CORTEX; FRONTOTEMPORAL DEMENTIA; GENE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; NEOCORTEX; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; PYRAMIDAL TRACT; REVIEW; TDP 43 PROTEINOPATHY; TEMPORAL CORTEX;

BRAIN; DNA REPEAT EXPANSION; DNA-BINDING PROTEINS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; NEURODEGENERATIVE DISEASES; PHENOTYPE; PROTEINS;

EID: 84896697357     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-013-1232-4     Document Type: Review

References (69)

1. Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al. (2011) p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 122:691-702. doi: 10.1007/s00401-011-0911-2
2. Almeida S, Gascon E, Tran H, Chou HJ, Gendron TF, Degroot S, et al. (2013) Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons. Acta Neuropathol 126:385-399. doi: 10.1007/s00401-013-1149-y
3. Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, et al. (2009) Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathol 117:125-136. doi: 10.1007/s00401-008-0480-1
4. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, et al. (2013) Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77:639-646. doi: 10.1016/j.neuron.2013.02.004
5. Belzil VV, Bauer PO, Prudencio M, Gendron TF, Stetler CT, Yan IK, et al. (2013) Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol 126:895-905. doi: 10.1007/s00401-013-1199-1
6. Belzil VV, Gendron TF, Petrucelli L (2013) RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci 56:406-419. doi: 10.1016/j.mcn.2012.12.006
7. Bieniek KF, Murray ME, Rutherford NJ, Castanedes-Casey M, DeJesus-Hernandez M, Liesinger AM, et al. (2013) Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion. Acta Neuropathol 125:289-302. doi: 10.1007/s00401-012-1048-7
8. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, et al. (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135:765-783. doi: 10.1093/brain/aws004
9. Boxer AL, Mackenzie IR, Boeve BF, Baker M, Seeley WW, Crook R, et al. (2011) Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry 82:196-203. doi: 10.1136/jnnp.2009.204081
10. Brettschneider J, Van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, et al. (2012) Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 123:825-839. doi: 10.1007/s00401-012-0970-z
11. Buratti E, Baralle FE (2010) The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 7:420-429 (pii: 12205)
12. Burrell JR, Kiernan MC, Vucic S, Hodges JR (2011) Motor neuron dysfunction in frontotemporal dementia. Brain 134:2582-2594. doi: 10.1093/brain/awr195
13. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, et al. (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171:227-240
14. Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A, et al. (2013) Loss of function of C9orf72 causes motor deficits in a zebrafish model of Amyotrophic Lateral Sclerosis. Ann Neurol. doi: 10.1002/ana.23946
15. Cleary JD, Ranum LP (2013) Repeat-associated non-ATG (RAN) translation in neurological disease. Hum Mol Genet 22:R45-R51. doi: 10.1093/hmg/ddt371
16. Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, et al. (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135:751-764. doi: 10.1093/brain/awr365
17. Da Cruz S, Cleveland DW (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol 21:904-919. doi: 10.1016/j.conb.2011.05.029
18. Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D, et al. (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521-533. doi: 10.1007/s00401-006-0189-y
19. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245-256. doi: 10.1016/j.neuron.2011.09.011
20. Dickson DW, Baker M, Rademakers R (2010) Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 7:170-174. doi: 10.1159/000289231
21. Donnelly CJ, Zhang PW, Pham JT, Heusler AR, Mistry NA, Vidensky S, et al. (2013) RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention. Neuron 80:415-428. doi: 10.1016/j.neuron.2013.10.015
22. Gendron TF, Bieniek KF, Zhang YJ, Jansen-West K, Ash PE, Caulfield T, et al. (2013) Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 126:829-844. doi: 10.1007/s00401-013-1192-8
23. Gijselinck I, Engelborghs S, Maes G, Cuijt I, Peeters K, Mattheijssens M, et al. (2010) Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 67:606-616. doi: 10.1001/archneurol.2010.82
24. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, et al. (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11:54-65. doi: 10.1016/S1474-4422(11)70261-7
25. Halliday G, Bigio EH, Cairns NJ, Neumann M, Mackenzie IR, Mann DM (2012) Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects. Acta Neuropathol 124:373-382. doi: 10.1007/s00401-012-1030-4
26. Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, et al. (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135:709-722. doi: 10.1093/brain/awr354
27. Josephs KA, Whitwell JL, Murray ME, Parisi JE, Graff-Radford NR, Knopman DS, et al. (2013) Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain 136:455-470. doi: 10.1093/brain/aws324
28. Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, et al. (2013) Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci USA 110:E4530-E4539. doi: 10.1073/pnas.1318835110
29. Lee EB, Lee VM, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13:38-50. doi: 10.1038/nrn3121nrn3121
30. Lee YB, Chen HJ, Peres JN, Gomez-Deza J, Attig J, Stalekar M, et al. (2013) Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic. Cell reports. doi: 10.1016/j.celrep.2013.10.049
31. Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59:1077-1079
32. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B (2003) Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60:1094-1097
33. Luty AA, Kwok JB, Thompson EM, Blumbergs P, Brooks WS, Loy CT, et al. (2008) Pedigree with frontotemporal lobar degeneration - motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9. BMC Neurol 8:32. doi: 10.1186/1471-2377-8-32
34. Mackenzie IR, Baborie A, Pickering-Brown S, Plessis DD, Jaros E, Perry RH, et al. (2006) Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 112:539-549
35. Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, et al. (2006) The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129:3081-3090. doi: 10.1093/brain/awl271
36. Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427-434. doi: 10.1002/ana.21147
37. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. (2009) Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117:15-18. doi: 10.1007/s00401-008-0460-5
38. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119:1-4. doi: 10.1007/s00401-009-0612-2
39. Mackenzie IR, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9:995-1007. doi: 10.1016/S1474-4422(10)70195-2
40. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111-113. doi: 10.1007/s00401-011-0845-8
41. Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, et al. (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126:859-879. doi: 10.1007/s00401-013-1181-y
42. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, et al. (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135:736-750. doi: 10.1093/brain/awr361
43. Mann DM, Rollinson S, Robinson A, Bennion Callister J, Thompson JC, Snowden JS, et al. (2013) Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathologica Commun 1:68. doi: 10.1186/2051-5960-1-68
44. Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P, et al. (2013) C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol 126:845-857. doi: 10.1007/s00401-013-1200-z
45. Mori K, Arzberger T, Grasser FA, Gijselinck I, May S, Rentzsch K, et al. (2013) Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol 126:881-893. doi: 10.1007/s00401-013-1189-3
46. Mori K, Lammich S, Mackenzie IR, Forne I, Zilow S, Kretzschmar H, et al. (2013) hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations. Acta Neuropathol 125:413-423. doi: 10.1007/s00401-013-1088-7
47. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, et al. (2013) The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339:1335-1338. doi: 10.1126/science.1232927
48. Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, et al. (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 38:758-769. doi: 10.1038/ng1827
49. Murray ME, Dejesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR, et al. (2011) Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122:673-690. doi: 10.1007/s00401-011-0907-y
50. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133. doi: 10.1126/science.1134108
51. Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD, et al. (2007) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66:152-157. doi: 10.1097/nen.0b013e31803020b9
52. Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y, et al. (2009) Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137-149. doi: 10.1007/s00401-008-0477-9
53. Pearson JP, Williams NM, Majounie E, Waite A, Stott J, Newsway V, et al. (2011) Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p. J Neurol 258:647-655. doi: 10.1007/s00415-010-5815-x
54. Pikkarainen M, Hartikainen P, Alafuzoff I (2008) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J Neuropathol Exp Neurol 67:280-298
55. Rademakers R, Neumann M, Mackenzie IR (2012) Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 8:423-434. doi: 10.1038/nrneurol.2012.117
56. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257-268. doi: 10.1016/j.neuron.2011. 09.010
57. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65:586-590. doi: 10.1212/01.wnl.0000172911.39167.b6
58. Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A, et al. (2006) Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169:1343-1352. doi: 10.2353/ajpath.2006.060438
59. Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, et al. (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135:723-735. doi: 10.1093/brain/awr353
60. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM, et al. (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135:693-708. doi: 10.1093/brain/awr355
61. Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, et al. (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 123:409-417. doi: 10.1007/s00401-011-0937-5
62. Treusch S, Cyr DM, Lindquist S (2009) Amyloid deposits: protection against toxic protein species? Cell Cycle 8:1668-1674
63. Troakes C, Maekawa S, Wijesekera L, Rogelj B, Siklos L, Bell C, et al. (2012) An MND/ALS phenotype associated with C9orf72 repeat expansion: abundant p62-positive, TDP-43-negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline. Neuropathology 32:505-514. doi: 10.1111/j.1440-1789.2011.01286.x
64. Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, et al. (2008) Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555-564. doi: 10.1097/NEN.0b013e31817713b5
65. van Blitterswijk M, DeJesus-Hernandez M, Rademakers R (2012) How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? Curr Opin Neurol 25:689-700. doi: 10.1097/WCO.0b013e32835a3efb
66. Wojciechowska M, Krzyzosiak WJ (2011) Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 20:3811-3821. doi: 10.1093/hmg/ddr299
67. Xi Z, Zinman L, Moreno D, Schymick J, Liang Y, Sato C, et al. (2013) Hypermethylation of the CpG Island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet 92:981-989. doi: 10.1016/j.ajhg.2013.04.017
68. Xu Z, Poidevin M, Li X, Li Y, Shu L, Nelson DL, et al. (2013) Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci USA 110:7778-7783. doi: 10.1073/pnas.1219643110
69. Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, et al. (2011) Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci USA 108:260-265. doi: 10.1073/pnas.1013343108